Coltura Spins Off EVQ, a New Venture to Accelerate EV Adoption

With federal EV incentives gone, Coltura is seizing on EVs' significant cost savings on fuel and maintenance to boost EVs directly in the marketplace by spinning off a new public benefit corporation, EVQ. EVQ offers powerful new tools to help NGOs, governments and utilities directly convert high-gasoline users to EVs. We have partnered with the […]

Parks Associates Examines Edge AI Innovations in Evolving IoT Ecosystem

New research in partnership with Silicon Labs highlights $12+ billion AI service market opportunity Parks Associates today released the new white paperAI Acceleration at the Edge: Optimizing Product Design, developed in partnership with Silicon Labs. The research explores how device manufacturers are unlocking new value for their connected devices with artificial intelligence (AI) capabilities embedded

Verizon helps families stay connected as Hurricane Melissa makes landfall in Jamaica

Verizon helps families stay connected as Hurricane Melissa makes landfall in Jamaica GlobeNewswire October 29, 2025 Free calling/texting/data for customers in Jamaica, Turks and Caicos, and the Bahamas and free calling from the US to these countries until Nov 12 What you need to know: In response to Hurricane Melissa, Verizon is offering free wireless

Clear Street’s Event-Driven Team Further Expands

NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) — Clear Street (“Clear Street” or the “Company”), a cloud-native financial infrastructure technology firm on a mission to give sophisticated investors access to every asset in every market, today announced an expansion of its Global Event-Driven Strategies team, appointing Sanjay Pall as Director in London. Pall's addition strengthens

Clear Street’s Outsourced Trading Team Further Expands

Strengthened by the Firm's Global Platform Sales Team, Providing Clients Seamless Access to its Expanding Suite of Solutions Brings on Senior Hires from UBS and Northern Trust NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) — Clear Street (“Clear Street” or the “Company”), a cloud-native financial infrastructure technology firm on a mission to give sophisticated investors

Clear Street’s Event-Driven Team Further Expands

Clear Street's Event-Driven Team Further Expands Serves Global Mandates for One Unified Client Experience Across Markets GlobeNewswire October 29, 2025 NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) — Clear Street (“Clear Street” or the “Company”), a cloud-native financial infrastructure technology firm on a mission to give sophisticated investors access to every asset in every market,

Clear Street’s Outsourced Trading Team Further Expands

Clear Street's Outsourced Trading Team Further Expands GlobeNewswire October 29, 2025 Strengthened by the Firm's Global Platform Sales Team, Providing Clients Seamless Access to its Expanding Suite of Solutions Brings on Senior Hires from UBS and Northern Trust NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) — Clear Street (“Clear Street” or the “Company”), a cloud-native

Sadaf Foods’ Quest to Create the World’s Most Perfect Coffee

Sadaf Launches Air Roasted, 100% Arabica Coffee Whether its Turkish, Greek, Armenian or other Mediterranean styles, any coffee aficionado knows a delicious cup of coffee all comes down to the quality of the coffee beans. For Sadaf Foods, the premier U.S. source of the finest Middle Eastern and Mediterranean specialty culinary products, finding the world's

From Exam Room to Courtroom: Med Legal Pro’s Tracy Liberatore Launches New Podcast “Statutes & Stethoscopes”

A compelling new podcast has entered the med-legal space. Statutes & Stethoscopes, hosted by physician assistant-turned-trial attorney Tracy Liberatore, dives deep into the high-stakes intersection of clinical care and courtroom advocacy. Produced by Med Legal Pro, this bi-weekly series dissects the critical role medical evidence plays in litigation-and how experts on both sides navigate it.

Akston Pioneers a New Generation of Cancer Therapy for Dogs in Clinical Trial Launch

Akston's first Ambifect® immuno-enhancing protein enters clinical trial at Purdue University, with Dutch Shepherd Rocco as the first patient — Akston has launched a clinical study at Purdue University for its Ambifect® immuno-enhancing therapy designed to induce antibodies targeting PD-L1 in dogs with solid tumors. — The novel Ambifect® therapy aims to dramatically reduce treatment

Scroll to Top